Freestone Grove Partners LP Moderna, Inc. Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Moderna, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 14,272 shares of MRNA stock, worth $387,342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,272Holding current value
$387,342% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
861Shares Held
267MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$694 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$600 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$469 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$241 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...